Skip to main content
    H

    HeartSciences Inc. (HSCS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.83
    +0.16 (+5.99%)

    Market Cap: $15.40M

    Last updated: Nov 06, 2026 at 4:04 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(9/17)
    Avg Surprise
    -27.68%

    Upcoming Estimates

    Period ending Oct 31, 2026
    EPS Consensus$-0.62
    Range$-0.62 - $-0.62
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.69+10.8%
    60d ago$-0.65+4.6%
    30d ago$-0.65+4.6%
    7d ago$-0.620.0%
    Current$-0.62
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Jan 31, 2027
    EPS Consensus$-0.61
    Range$-0.61 - $-0.61
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.72+15.3%
    60d ago$-0.66+7.6%
    30d ago$-0.66+7.6%
    7d ago$-0.610.0%
    Current$-0.61
    Revenue Consensus
    $5000
    Range$5000 - $5000
    1 analysts
    Last 12 of 18 reported quarters and 3 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Apr 27EST
    		-$-0.51$-0.51 - $-0.51--1--
    Jan 27EST
    		-$-0.61$-0.61 - $-0.61--1
    1
    0
    30d
    		-
    Oct 26EST
    		-$-0.62$-0.62 - $-0.62--1
    1
    0
    30d
    		-
    Jul 26
    Reported Sep 14
    		$-0.86$-0.78$-0.78 - $-0.78-10.26%Miss1
    0
    1
    30d
    		+45.6%
    Apr 26
    Reported Jul 23
    		$-0.88$-0.73$-0.74 - $-0.72-20.55%Miss2
    2
    0
    30d
    		+53.2%
    Jan 26
    Reported Mar 16
    		$-0.63$-0.88$-0.92 - $-0.84+28.41%Beat2
    2
    0
    30d
    		+75.5%
    Oct 25
    Reported Dec 15
    		$-0.85$-1.27$-1.65 - $-0.90+33.07%Beat2
    1
    1
    30d
    		+62.6%
    Jul 25
    Reported Sep 11
    		$-1.58$-1.87$-2.03 - $-1.72+15.51%Beat2
    0
    1
    30d
    		+40.2%
    Apr 25
    Reported Jul 24
    		$-1.88$-2.14$-2.51 - $-1.78+12.15%Beat2
    1
    1
    30d
    		+90.0%
    Jan 25
    Reported Mar 13
    		$-2.57$-2.31$-2.53 - $-2.08-11.26%Miss2
    No revisions (30d)
    		+14.3%
    Oct 24
    Reported Dec 16
    		$-2.27$-2.33$-2.37 - $-2.30+2.58%Beat2
    0
    2
    30d
    		+85.8%
    Jul 24
    Reported Sep 12
    		$-2.64$-2.31$-2.83 - $-2.10-14.29%Miss2
    No revisions (30d)
    		+79.7%
    Apr 24
    Reported Jul 29
    		$-18.81$-3.00$-4.00 - $-3.00-527.00%Miss2
    No revisions (30d)
    		-8857.1%
    Jan 24
    Reported Mar 14
    		$-3.00$-6.00$-6.00 - $-6.00+50.00%Beat1
    No revisions (30d)
    		+81.3%
    Oct 23
    Reported Dec 14
    		$-16.00$-12.00$-12.00 - $-12.00-33.33%Miss1
    No revisions (30d)
    		+27.3%

    Key Metrics

    Valuation
    P/E Ratio-0.88EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-139957.00%
    ROE-1852.00%ROIC-408.80%
    Financial Health
    Debt/Equity-1.90xInterest Coverage-11.75x
    Current Ratio0.14xQuick Ratio0.07x
    Trading Statistics
    Beta1.81Avg Volume89.91K
    52-Week High$5.2552-Week Low$1.63

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.13
    SMA 20$3.15
    SMA 50$3.60
    SMA 200$2.70
    EMA 10$3.05
    EMA 20$3.20
    EMA 50$3.29
    EMA 200$2.95

    MACD

    Line: -0.18Signal: -0.14Hist: -0.04

    ADX

    ADX: 15.3+DI: 16.7-DI: 25.2

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down96.0
    PSAR$3.54

    Bollinger Bands

    Upper Band$3.59
    Lower Band$2.70
    %B Position2827%(Upper)
    Band Width0.14

    RSI (14-Day)

    Neutral
    41.9

    Momentum Oscillators

    Stoch %K17.3
    Stoch %D15.8
    Williams %R-80.2
    ROC (10d)-9.9%
    Momentum-0.31
    CCI (20d)-148.9
    MFI (14d)68.8

    Volatility Measures

    ATR (14d)$0.37(12.9%)
    StdDev (20d)0.22
    Hist Vol110.2%(High)

    Volume Flow

    VWAP$2.87
    OBV137.6M
    AD Line-83.6M
    CMF (20d)-0.108

    Volume Metrics

    Avg Vol (20d)85.8K
    Vol Ratio0.9x
    VWMA (20d)$3.18

    Pivot Points

    R3$3.44
    R2$3.26
    R1$2.97
    Pivot Point$2.79
    S1$2.50
    S2$2.32
    S3$2.03

    Advanced Oscillators

    TSI-12.13
    Ultimate Osc36.9
    KST-159.22

    Financial Data

    QuarterJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total Revenue$2,100$89.49M$0$2,419$1,900$31$0$0$0$0$14,700$3,900
    Cost of Revenue$760$60.39M$0$1,008$760$112$0$0$0$9,201$4,561$1,520
    Gross Profit$1,340$29.11M$0$1,411$1,140$-81$0$0$0$-9,201$10,139$2,380
    Operating Expenses$2.94M$39.66M$1.93M$2.07M$1.88M$2.03M$2.37M$1.99M$2.08M$1.88M$1.54M$1.57M
    R&D$906,629$640.30M$638,575$727,026$997,206$1.63M$1.03M$1.20M$1.22M$1.05M$509,507$757,303
    SG&A$2.03M$9.94M$1.29M$1.35M$878,053$404,741$1.34M$786,068$850,736$833,678$1.03M$815,020
    Operating Income$-2,939,090$-10,554,538$-1,928,940$-2,073,403$-1,874,119$-2,033,577$-2,371,472$-1,985,033$-2,075,667$-1,879,790$-1,525,382$-1,569,943
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$235,261$524,731$61,509$279,534$183,688$-142,246$179,477$117,598$22,526$20,937$118,445$178,438
    Income Before Tax$-3,172,344$-9,968,029$-1,985,208$-2,350,769$-2,054,994$-1,823,174$-2,536,292$-2,082,918$-2,051,689$-1,846,164$-1,643,811$-1,748,378
    Income Tax Expense$0$-3,683,000$0$0$0$0$0$0$0$0$0$0
    Net Income$-3,172,344$-6,285,029$-1,985,208$-2,350,769$-2,054,994$-1,823,174$-2,536,292$-2,082,918$-2,051,689$-1,846,164$-1,643,811$-1,748,378
    EBITDA$-2,801,722$21.98M$-1,923,699$-1,970,855$-1,729,681$-1,824,209$-2,217,898$-1,669,005$-1,887,538$-1,795,266$-1,480,842$-1,472,533
    EBIT$-2,937,083$-10,492,760$-1,923,699$-2,071,235$-1,871,306$-1,965,420$-2,356,815$-1,965,320$-2,029,163$-1,825,227$-1,525,366$-1,569,940
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HSCS

    HSCS Valuation and Fair Value

    P/E
    -0.9x
    P/B
    -5.1x
    See GNG's fair value

    HSCS Profitability: Margins, ROIC and FCF

    Operating margin
    -139957.0%
    Net margin
    0.0%
    ROIC
    -408.8%
    ROE
    -1852.0%

    HSCS Competitors

    CompanyTicker
    Cyclerion Therapeutics IncCYCN
    Citius Pharmaceuticals IncCTXR
    Concord Medical Services HoldingsCCM
    Neuphoria Therapeutics IncNEUP
    SRx Health Solutions Inc.SRXH
    Marker Therapeutics IncMRKR
    Lifeward Ltd.LFWD
    MDxHealth SAMDXH

    Sector: Healthcare

    HSCS Bull Case vs Bear Case

    Bull case

    • HSCS grew quarterly revenue 10.5% year over year.

    HSCS Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    6.2%
    EPS estimate (fiscal period ending Oct 31, 2026)
    $-0.62
    Estimate revisions (30 days, fiscal period ending Oct 31, 2026)
    1 up, 0 down

    HSCS Earnings Date

    HSCS reports Dec 21, 2026. The date is confirmed.

    Frequently Asked Questions About HSCS

    When does HSCS report earnings?

    HeartSciences Inc. (HSCS) is confirmed to report earnings on Dec 21, 2026.

    Does HSCS pay dividends?

    HeartSciences Inc. (HSCS) does not currently pay a regular dividend.

    What is HSCS's market cap?

    HeartSciences Inc. (HSCS) has a market capitalization of $15.40M with a current stock price of $2.83.

    Related stocks

    Sector: Healthcare

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In